Page 1814 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1814

1616.e2  Part X  Transplantation


        43.  Fernandez-Vina MA, Klein JP, Haagenson M, et al: Multiple mismatches   54.  Horton  R,  Gibson  R,  Coggill  P,  et al:  Variation  analysis  and  gene
           at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with   annotation  of  eight  MHC  haplotypes:  the  MHC  Haplotype  Project.
           adverse  outcomes  in  hematopoietic  stem  cell  transplantation.  Blood   Immunogenetics 60:1–18, 2008.
           121:4603–4610, 2013.                               55.  Tamouza R, Busson M, Rocha V, et al: Homozygous status for HLA-
        44.  Petersdorf EW, Hansen JA, Martin PJ, et al: Major-histocompatibility-  E*0103  confers  protection  from  acute  graft-versus-host  disease  and
           complex class I alleles and antigens in hematopoietic-cell transplantation.   transplant-related mortality in HLA-matched sibling hematopoietic stem
           N Engl J Med 345:1794–1800, 2001.                     cell transplantation. Transplantation 82:1436–1440, 2006.
        45.  Ferrara GB, Bacigalupo A, Lamparelli T, et al: Bone marrow transplanta-  56.  Parmar S, Del Lima M, Zou Y, et al: Donor-recipient mismatches in
           tion from unrelated donors: the impact of mismatches with substitutions   MHC class I chain-related gene A in unrelated donor transplantation
           at position 116 of the human leukocyte antigen class I heavy chain. Blood   lead  to  increased  incidence  of  acute  graft-versus-host  disease.  Blood
           98:3150–3155, 2001.                                   114:2884–2887, 2009.
        46.  Kawase T, Morishima Y, Matsuo K, et al: High-risk HLA allele mismatch   57.  Bettens F, Passweg J, Schanz U, et al: Impact of HLA-DPB1 haplotypes
           combinations  responsible  for  severe  acute-graft-versus-host  disease   on outcome of 10/10 matched unrelated hematopoietic stem cell donor
           and  implication  for  its  molecular  mechanism.  Blood  110:2235–2241,   transplants depends on MHC-linked microsatellite polymorphisms. Biol
           2007.                                                 Blood Marrow Transplant 18:608–616, 2012.
        47.  Kawase T, Matsuo K, Kashiwase K, et al: HLA mismatch combinations   58.  de  Bakker  PI,  McVean  G,  Sabeti  PC,  et al:  A  high-resolution  HLA
           associated with decreased risk of relapse: implications for the molecular   and SNP haplotype map for disease association studies in the extended
           mechanism. Blood 113:2851–2858, 2009.                 human MHC. Nat Genet 38:1166–1172, 2006.
        48.  Pidala  J,  Wang  T,  Haagenson  M,  et al:  Amino  acid  substitution  at   59.  Guo  Z,  Hood  L,  Malkki  M,  et al:  Long-range  multilocus  haplotype
           peptide-binding pockets of HLA class I molecules increases risk of severe   phasing of the MHC [erratum appears in Proc Natl Acad Sci U S A.
           acute GVHD and mortality. Blood 122:3651–3658, 2013.  2006 Jun 13;103(24):9374]. Proc Natl Acad Sci USA 103:6964–6969,
        49.  Fleischhauer K, Shaw BE, Gooley T, et al: Effect of T-cell-epitope match-  2006.
           ing  at  HLA-DPB1  in  recipients  of  unrelated-donor  haemopoietic-cell   60.  Petersdorf EW, Malkki M, Gooley TA, et al: MHC haplotype matching
           transplantation: a retrospective study. [Erratum appears in Lancet Oncol.   for unrelated hematopoietic cell transplantation. PLoS Med 4:e8, 2007.
           2012 Apr;13(4):e134-5]. Lancet Oncol 13:366–374, 2012.  61.  Baschal EE, Aly TA, Jasinski JM, et al: Defining multiple common “com-
        50.  Zino E, Frumento G, Marktel S, et al: A T-cell epitope encoded by a   pletely”  conserved  major  histocompatibility  complex  SNP  haplotypes.
           subset of HLA-DPB1 alleles determines nonpermissive mismatches for   Clin Immunol 132:203–214, 2009.
           hematologic stem cell transplantation. Blood 103:1417–1424, 2004.  62.  Morishima S, Ogawa S, Matsubara A, et al: Impact of highly conserved
        51.  Pidala J, Lee SJ, Ahn KW, et al: Nonpermissive HLA-DPB1 mismatch   HLA haplotype on acute graft-versus-host disease. Blood 115:4664–4670,
           increases mortality after myeloablative unrelated allogeneic hematopoi-  2010.
           etic cell transplantation. Blood 124:2596–2606, 2014.  63.  Petersdorf EW, Malkki M, Gooley TA, et al: MHC-resident variation
        52.  Apps R, Qi Y, Carlson JM, et al: Influence of HLA-C expression level   affects risks after unrelated donor hematopoietic cell transplantation. Sci
           on HIV control. Science 340:87–91, 2013.              Transl Med 4:144ra101, 2012.
        53.  Petersdorf EW, Gooley TA, Malkki M, et al: HLA-C expression levels   64.  Petersdorf EW, Malkki M, Horowitz MM, et al: Mapping MHC haplo-
           define  permissible  mismatches  in  hematopoietic  cell  transplantation.   type effects in unrelated donor hematopoietic cell transplantation. Blood
           Blood 124:3996–4003, 2014.                            121:1896–1905, 2013.
   1809   1810   1811   1812   1813   1814   1815   1816   1817   1818   1819